Literature DB >> 26969468

Direct brain infusion can be enhanced with focused ultrasound and microbubbles.

Shutao Wang1, Maria E Karakatsani1, Christine Fung1, Tao Sun1, Camilo Acosta1, Elisa Konofagou1,2.   

Abstract

The delivery of most therapeutic agents is rendered ineffective for the treatment of brain diseases due to the presence of the blood-brain barrier (BBB). The goal of this study was to investigate the effect of pre-infusion focused ultrasound (FUS) and microbubbles on the distribution of direct brain infusion in vivo. A single-element FUS transducer was used in all sonications, which were carried out immediately prior to direct infusion procedures. Mice received direct infusion of either Gadolinium-labeled albumin (Gd-albumin, 74 kDa) or adeno-associated virus (AAV, ∼4 MDa). The volumes of Gd-albumin at 30 min were deemed comparable ( P = 0.334) between the direct infusion (DI)-only group and the FUS + DI group. At 120 min, the FUS + DI group showed significantly higher contrast-enhanced volume (9.76 ± 0.74 mm3) than the DI-only group (7.14 ± 0.34 mm3). For mice infused with AAV, the total volume of transduction was estimated as GFP-positive regions and FUS + DI group demonstrated significantly higher ( P = 0.017) transduction efficiency in vivo. In conclusion, enhanced bio-distribution of directly infused agents was observed when the targeted region was pre-conditioned with FUS and microbubbles. Focused ultrasound has the potential, as an adjuvant technique, to significantly enhance direct brain infusion and achieve the desired therapeutic outcomes.

Entities:  

Keywords:  MRI; Ultrasound; gene therapy; microscopy; neurosurgery

Mesh:

Substances:

Year:  2016        PMID: 26969468      PMCID: PMC5381459          DOI: 10.1177/0271678X16637881

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  27 in total

Review 1.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 2.  Ultrasound-biophysics mechanisms.

Authors:  William D O'Brien
Journal:  Prog Biophys Mol Biol       Date:  2006-08-08       Impact factor: 3.667

Review 3.  Targeted delivery of protein and gene medicines through the blood-brain barrier.

Authors:  W M Pardridge
Journal:  Clin Pharmacol Ther       Date:  2014-12-15       Impact factor: 6.875

4.  Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.

Authors:  Stéphane Palfi; Jean Marc Gurruchaga; G Scott Ralph; Helene Lepetit; Sonia Lavisse; Philip C Buttery; Colin Watts; James Miskin; Michelle Kelleher; Sarah Deeley; Hirokazu Iwamuro; Jean Pascal Lefaucheur; Claire Thiriez; Gilles Fenelon; Cherry Lucas; Pierre Brugières; Inanna Gabriel; Kou Abhay; Xavier Drouot; Naoki Tani; Aurelie Kas; Bijan Ghaleh; Philippe Le Corvoisier; Patrice Dolphin; David P Breen; Sarah Mason; Natalie Valle Guzman; Nicholas D Mazarakis; Pippa A Radcliffe; Richard Harrop; Susan M Kingsman; Olivier Rascol; Stuart Naylor; Roger A Barker; Philippe Hantraye; Philippe Remy; Pierre Cesaro; Kyriacos A Mitrophanous
Journal:  Lancet       Date:  2014-01-10       Impact factor: 79.321

5.  A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme.

Authors:  Edward White; Alison Bienemann; Hannah Taylor; Kirsten Hopkins; Alison Cameron; Steven Gill
Journal:  Contemp Clin Trials       Date:  2011-11-12       Impact factor: 2.226

6.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

7.  AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.

Authors:  Peter A LeWitt; Ali R Rezai; Maureen A Leehey; Steven G Ojemann; Alice W Flaherty; Emad N Eskandar; Sandra K Kostyk; Karen Thomas; Atom Sarkar; Mustafa S Siddiqui; Stephen B Tatter; Jason M Schwalb; Kathleen L Poston; Jaimie M Henderson; Roger M Kurlan; Irene H Richard; Lori Van Meter; Christine V Sapan; Matthew J During; Michael G Kaplitt; Andrew Feigin
Journal:  Lancet Neurol       Date:  2011-04       Impact factor: 44.182

8.  The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice.

Authors:  Yao-Sheng Tung; Fotios Vlachos; Jameel A Feshitan; Mark A Borden; Elisa E Konofagou
Journal:  J Acoust Soc Am       Date:  2011-11       Impact factor: 1.840

9.  Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.

Authors:  Kullervo Hynynen; Nathan McDannold; Nickolai A Sheikov; Ferenc A Jolesz; Natalia Vykhodtseva
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

10.  Noninvasive and transient blood-brain barrier opening in the hippocampus of Alzheimer's double transgenic mice using focused ultrasound.

Authors:  James J Choi; Shougang Wang; Truman R Brown; Scott A Small; Karen E K Duff; Elisa E Konofagou
Journal:  Ultrason Imaging       Date:  2008-07       Impact factor: 1.578

View more
  12 in total

1.  Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease.

Authors:  Paul S Fishman; Victor Frenkel
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

Review 2.  Strategies for delivering therapeutics across the blood-brain barrier.

Authors:  Georg C Terstappen; Axel H Meyer; Robert D Bell; Wandong Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-03-01       Impact factor: 84.694

3.  Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA.

Authors:  Heng Li; Hironori Okada; Sadafumi Suzuki; Kazuhisa Sakai; Hitomi Izumi; Yukiko Matsushima; Noritaka Ichinohe; Yu-Ichi Goto; Takashi Okada; Ken Inoue
Journal:  JCI Insight       Date:  2019-05-16

4.  A Comparison of Focused and Unfocused Ultrasound for Microbubble-Mediated Gene Delivery.

Authors:  Cynthia D Anderson; Chad B Walton; Ralph V Shohet
Journal:  Ultrasound Med Biol       Date:  2021-03-31       Impact factor: 3.694

Review 5.  Treatment of Movement Disorders With Focused Ultrasound.

Authors:  Paul S Fishman; Victor Frenkel
Journal:  J Cent Nerv Syst Dis       Date:  2017-06-06

Review 6.  In vivo methods for acute modulation of gene expression in the central nervous system.

Authors:  Andrzej W Cwetsch; Bruno Pinto; Annalisa Savardi; Laura Cancedda
Journal:  Prog Neurobiol       Date:  2018-04-22       Impact factor: 11.685

7.  Progress in brain barriers and brain fluid research in 2017.

Authors:  Richard F Keep; Hazel C Jones; Lester R Drewes
Journal:  Fluids Barriers CNS       Date:  2018-02-02

8.  Focused shockwave induced blood-brain barrier opening and transfection.

Authors:  Yi Kung; Chiang Lan; Ming-Yen Hsiao; Ming-Kuan Sun; Yi-Hua Hsu; Abel P-H Huang; Wei-Hao Liao; Hao-Li Liu; Claude Inserra; Wen-Shiang Chen
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

9.  MR-guided transcranial focused ultrasound safely enhances interstitial dispersion of large polymeric nanoparticles in the living brain.

Authors:  David S Hersh; Pavlos Anastasiadis; Ali Mohammadabadi; Ben A Nguyen; Sijia Guo; Jeffrey A Winkles; Anthony J Kim; Rao Gullapalli; Asaf Keller; Victor Frenkel; Graeme F Woodworth
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

Review 10.  Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities.

Authors:  Colleen T Curley; Natasha D Sheybani; Timothy N Bullock; Richard J Price
Journal:  Theranostics       Date:  2017-08-23       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.